← All stocks

Xenon Pharmaceuticals Inc.

XENE Mostly scheduled

CIK 0001582313 #1255 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$22.97M

$3.26M on a plan · $19.07M straight out of an exercise

Sold at will

$640.55K

1 of 27 sales

Net

−$22.97M

−$640.55K against sales at will

By person

11 insiders · 29 transactions

1.5×

Ian Mortimer holds only 1.5 times base salary in stock. $1.21M of shares against $786.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ian Mortimer last reported holding, valued at $60.98, the price Common Shares was last bought or sold at on the open market here, on 28 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MORTIMER IAN

PRESIDENT & CEO

—

$21.30M (18) scheduled

−$21.30M

19,923

0.0206%

$1.21M

−36.4%

KENNEY CHRISTOPHER JOHN

Chief Medical Officer

—

$670.26K (4) scheduled

−$670.26K

<0.0001%

$121.95

+100.0%

GANNON STEVEN

Director

—

$640.55K (1)

−$640.55K

1,870

0.0019%

$114.03K

−6.5%

DiFabio Andrea

Chief Legal Officer

—

$230.81K (2) scheduled

−$230.81K

7,301

0.0075%

$445.19K

—

PATOU GARY

Director

—

$70.25K (1) scheduled

−$70.25K

24,896

0.0257%

$1.52M

+5.6%

Cannon Gillian

Director

—

$63.24K (1) scheduled

−$63.24K

1,455

0.0015%

$88.72K

—

Svoronos Dawn

Director

—

31,373

0.0324%

$1.91M

+25.5%

Machado Patrick

Director

—

2,645

0.0027%

$161.28K

—

Gover Justin D.

Director

—

2,645

0.0027%

$161.28K

—

GAROFALO ELIZABETH A.

Director

—

2,645

0.0027%

$161.28K

—

AULIN SHERRY

Chief Financial Officer

—

0.0000%

$0.00

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

GANNON STEVEN

11 Aug 2026

Director

Sell

10,000

$64.06

$640.55K

Show all 29 transactions →

What was left out

Form 4 filings counted 28

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 14

Sales straight out of an exercise 12

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 419,991

History held since 27 Sep 2016